老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Evofem Biosciences, Inc.

0.0089
0.0000
成交量：8,124.00
成交額：72.30
市值：117.95萬
市盈率：25.00
高：0.0089
開：0.0089
低：0.0089
收：0.0089
52周最高：0.0200
52周最低：0.0069
股本：1.33億
流通股本：1.13億
量比：0.18
換手率：0.01%
股息：- -
股息率：- -
每股收益(TTM):0.0004
每股收益(LYR):0.0004
淨資產收益率：-387.27%
總資產收益率：4.08%
市淨率：-0.02
市盈率(LYR):25.00

資料載入中...

總覽公司新聞資訊公告
2020/04/27

重要事件披露

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
2020/04/17

重要事件披露

Current report, item 1.01
2020/03/25

重要事件披露

Current report, items 1.01, 3.03, 5.03, 8.01, and 9.01
2020/03/12

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/12

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/12

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/03/09

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/26

重要事件披露

Current report, items 5.02 and 9.01
2020/02/13

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/10

重要事件披露

Current report, items 7.01 and 9.01
2019/12/16

重要事件披露

Current report, item 5.02
2019/12/02

重要事件披露

Current report, items 8.01 and 9.01
2019/11/26

SEC問詢函

[Cover]Correspondence
2019/11/26

重要事件披露

Current report, items 8.01 and 9.01
2019/11/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/10/29

超過5%披露

Statement of acquisition of beneficial ownership by individuals
更多